All Roll Calls
Yes: 127 • No: 1
UtahS.B. 2222026 General SessionSenateWALLET
Right to Try Amendments
Sponsored By: Chris H. Wilson (Republican)
Signed by Governor
Health and Human ServicesHealth Care
Your PRIA Score
Score Hidden
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
2 provisions identified: 0 benefits, 1 costs, 1 mixed.
Manufacturers must file annual patient reports
Beginning May 6, 2026, a manufacturer that gives an investigational drug or device to a Utah patient must file a report. Send it to the Health and Human Services Interim Committee before November 1 after the product was provided. The report lists how many patients got the product, which illnesses were treated, and likely adverse outcomes. Reports are not required if the patient was in an FDA clinical investigation.
New rules for patients using trial treatments
Beginning May 6, 2026, the law updates who can use investigational drugs or devices in Utah. Cancer counts as a terminal illness when a board-certified oncologist says so. A patient must have a life-threatening or severely debilitating condition and, after exploring standard treatments, no option that is satisfactory or comparable. A Utah-licensed physician must diagnose the terminal or eligible illness. The product must have finished FDA Phase 1 testing and be in an FDA-compliant clinical study.
Free Policy Watch
You just read the policy. Now see what it costs you.
Pick a topic. PRIA runs your household against live legislation and sends you a free personalized readout.
Pick a topic to get started
Sponsors & Cosponsors
Sponsor
Chris H. Wilson
Republican • Senate
Cosponsors
Clancy, Tyler
Affiliation unavailable
Roll Call Votes
House vote • 3/5/2026
House/ passed 3rd reading
Yes: 67 • No: 0
House vote • 2/27/2026
House Comm - Favorable Recommendation
Yes: 10 • No: 0
Senate vote • 2/23/2026
Senate/ substituted
Yes: 0 • No: 0
Senate vote • 2/23/2026
Senate/ circled
Yes: 0 • No: 0
Senate vote • 2/23/2026
Senate/ uncircled
Yes: 0 • No: 0
Senate vote • 2/23/2026
Senate/ passed 3rd reading
Yes: 24 • No: 0
Senate vote • 2/20/2026
Senate/ passed 2nd reading
Yes: 23 • No: 0
Senate vote • 2/20/2026
Senate/ substituted
Yes: 0 • No: 0
House vote • 2/3/2026
Senate Comm - Favorable Recommendation
Yes: 3 • No: 1
Actions Timeline
Governor Signed
3/18/2026Senate/ to Governor
3/13/2026SenateSenate/ received enrolled bill from Printing
3/13/2026SenateSenate/ enrolled bill to Printing
3/11/2026SenateEnrolled Bill Returned to House or Senate
3/11/2026Draft of Enrolled Bill Prepared
3/6/2026Bill Received from Senate for Enrolling
3/6/2026Senate/ signed by President/ sent for enrolling
3/6/2026SenateSenate/ received from House
3/6/2026SenateHouse/ to Senate
3/5/2026HouseHouse/ signed by Speaker/ returned to Senate
3/5/2026HouseHouse/ passed 3rd reading
3/5/2026HouseHouse/ 3rd reading
3/5/2026HouseHouse/ 2nd reading
3/2/2026HouseHouse/ committee report favorable
3/2/2026HouseHouse Comm - Favorable Recommendation
2/27/2026House/ to standing committee
2/25/2026HouseHouse/ 1st reading (Introduced)
2/24/2026HouseHouse/ received from Senate
2/23/2026HouseSenate/ to House
2/23/2026SenateSenate/ passed 3rd reading
2/23/2026SenateSenate/ uncircled
2/23/2026SenateSenate/ circled
2/23/2026SenateSenate/ substituted
2/23/2026SenateSenate/ 3rd reading
2/23/2026Senate
Bill Text
Enrolled
3/11/2026
Substitute #2
2/23/2026
Substitute #1
2/17/2026
Introduced
1/29/2026
Related Bills
Take It Personal
Get Your Personalized Policy View
Take the PRIA Score to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in